Try our beta test site
79 studies found for:    "Patent ductus arteriosus"
Show Display Options
Rank Status Study
1 Terminated An Escalating Dose Indomethacin for the Treatment of Persistent Patent Ductus Arteriosus (PDA) In Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Indomethacin
2 Recruiting Early Ibuprofen Treatment of Patent Ductus Arteriosus (PDA) in Premature Infants (TRIOCAPI)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen;   Drug: Placebo
3 Unknown  Treating the Resistant Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Drug: Pentoxifylline
4 Completed Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Interventions: Drug: Ibuprofen EchoG;   Drug: Standard ibuprofen treatment
5 Not yet recruiting IV Acetaminophen and Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Interventions: Drug: Acetaminophen;   Drug: Ibuprofen
6 Unknown  Paracetamol and Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Interventions: Drug: Paracetamol;   Drug: NSAID;   Drug: D5W
7 Completed Comparison of 2 Different Indomethacin Dosing Protocols to Treat Infants Delivered at <28 Weeks Gestation With a Persistent Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Drug: indomethacin (two different dosing regimens)
8 Completed Closure of Patent Ductus Arteriosus With Indomethacin or Ibuprofen in Extreme Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Intervention: Drug: Ibuprofen
9 Completed Timing for the Medical Treatment of Patent Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
10 Recruiting Near Infrared Spectroscopy to Determine Patent Ductus Arteriosus Closure
Condition: Patent Ductus Arteriosus
Intervention: Device: near infrared spectroscopy
11 Completed Safety and Effectiveness Study With a New PDA Occluder for Closure of Patent Ductus Arteriosus
Condition: Patent Ductus Arteriosus
Intervention: Device: Occlutech PDA occluder
12 Not yet recruiting International Experience in Timing And Choices for Ductal Closure in Patent Ductus Arteriosus:INTERPDA Trial
Condition: Patent Ductus Arteriosus
Intervention: Device: Echocardiography
13 Recruiting Platelet Transfusion for Treatment of Patent Ductus Arteriosus in Thrombocytopenic Preterm Neonates
Condition: Patent Ductus Arteriosus
Interventions: Biological: Liberal platelet transfusion;   Biological: Restrictive platelet transfusion;   Drug: Paracetamol;   Drug: Ibuprofen
14 Completed Nitric Oxide, Endothelin-1, and the Patency of Ductus Arteriosus in Preterm Infants
Condition: Patent Ductus Arteriosus
Intervention:
15 Completed Comparative Study of Efficacy and Safety of Oral Ibuprofen and Intravenous Ibuprofen in Closure of Patent Ductus Arteriosus in Very Low Birth Weight Infants
Condition: Patent Ductus Arteriosus
Interventions: Drug: oral ibuprofen;   Drug: intravenous ibuprofen
16 Completed Influence of Treatment for Patent Ductus Arteriosus on Cerebral Oxygenation in Preterm Infants
Conditions: Prematurity of Fetus;   Patent Ductus Arteriosus
Interventions: Drug: Indomethacin;   Procedure: Surgical Ligation;   Drug: Ibuprofen
17 Completed High-dose Ibuprofen for Patent Ductus Arteriosus (PDA) in Preterm Infant
Condition: Ductus Arteriosus, Patent
Intervention: Drug: Ibuprofen
18 Active, not recruiting
Has Results
AMPLATZER Duct Occluder II Clinical Study
Condition: Patent Ductus Arteriosus
Intervention: Device: AMPLATZER Duct Occluder II
19 Completed
Has Results
Closure Of Patent Ductus Arteriosus With the AMPLATZER Duct Occluder the AMPLATZER® Duct Occluder
Condition: Patent Ductus Arteriosus (PDA)
Interventions: Device: Device closure with AMPLATZER Duct Occluder;   Other: Objective Performance Criteria
20 Completed Safety and Efficacy of Ibuprofen in Term Newborns With Patent Ductus Arteriosus (PDA)
Condition: Patent Ductus Arteriosus
Intervention: Drug: Oral Ibuprofen

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.